TomaszM.BeerMD

Oncology • Portland, OR

Genitourinary Oncology, Hematologic Oncology

Professor of Medicine at OHSU Knight Cancer Institute

Join to view full profile

Dr. Beer is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Beer's full profile

Already have an account?

Office
3303 SW Bond Ave, CH14R
Portland, OR 97239
Phone+1 503-494-6594
Is this information wrong?

Education & Training

Oregon Health & Science UniversityFellowship, Hematology and Medical Oncology, 1996 - 1999
Oregon Health & Science UniversityResidency, Internal Medicine, 1991 - 1996
Johns Hopkins University School of MedicineClass of 1991

Certifications & Licensure

OR State Medical License 1992 - 2025
WA State Medical License 1994 - 1996
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2007-2014
America's Top Doctors for Cancer Castle Connolly, 2006-2013
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Portland Monthly Magazine Castle Connolly, 2011
Fellow (FACP) American College of Physicians, 2005
Join now to see all

Clinical Trials

Docetaxel in Treating Patients With Stage IV Prostate Cancer Start of enrollment: 1998 Dec 01
Completed
Phase 2
Calcitriol in Treating Patients With a Rising PSA Level Following Treatment for Prostate Cancer Start of enrollment: 1999 Feb 01
Completed
Phase 2
Combination Chemotherapy Followed by Surgery in Treating Patients With Localized Prostate Cancer Start of enrollment: 2000 Sep 01
Completed
Phase 2
Calcitriol and Carboplatin in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy Start of enrollment: 2000 Dec 01
Completed
Phase 2
Arsenic Trioxide in Treating Men With Germ Cell Cancer Start of enrollment: 2002 Apr 01
Completed
Phase 2
ASCENT: Androgen Independent Prostate Cancer Study of Calcitriol Enhancing Taxotere Start of enrollment: 2002 Aug 01
Unknown status
Phase 2, Phase 3
S0224, Docetaxel in Treating Patients With Locally Advanced or Metastatic Penile Cancer (TERMINATED) Start of enrollment: 2004 Oct 01
Terminated
Phase 2
S0306, Irinotecan in Treating Patients With Recurrent or Refractory Advanced Transitional Cell Cancer of the Urothelium Previously Treated With Chemotherapy Start of enrollment: 2003 Jul 01
Completed
Phase 2
SB-715992 in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Docetaxel or Paclitaxel Start of enrollment: 2005 Apr 01
Completed
Phase 2
Acupuncture in Treating Hot Flashes in Patients With Prostate Cancer Start of enrollment: 2002 Sep 01
Terminated
Not Applicable
Study of Aranesp to Treat Anemia in Prostate Cancer Patients. Start of enrollment: 2003 Apr 01
Completed
Phase 2
Paclitaxel Poliglumex and Estradiol in Treating Patients With Stage IV Prostate Cancer Start of enrollment: 2007 Feb 01
Terminated
Phase 2
Docetaxel in Treating Patients With Relapsed Prostate Cancer Start of enrollment: 2007 May 01
Terminated
Phase 2
A Study Evaluating the Pain Palliation Benefit of Adding Custirsen to Docetaxel Retreatment or Cabazitaxel as Second Line Therapy in Men With Metastatic Castrate Resistant Prostate Cancer (mCRPC) Start of enrollment: 2010 Mar 01
Terminated
Phase 3
Phenelzine Sulfate and Docetaxel in Treating Patients With Prostate Cancer With Progressive Disease After First-Line Therapy With Docetaxel Start of enrollment: 2010 Jul 12
Terminated
Phase 2
Dietary Fat Levels and Abiraterone Acetate Uptake in Patients With Metastatic Hormone-Resistant Prostate Cancer Start of enrollment: 2013 Jul 01
Terminated
Phase 1
Observational Longitudinal Study of Pain in Men With Metastatic Castrate-Resistant Prostate Cancer Start of enrollment: 2014 Jan 23
Completed
Assessment of the Implementation of an Investigational Multi-Cancer Early Detection Test Into Clinical Practice Start of enrollment: 2019 Dec 12
Completed
Not Applicable
Join now to see all

Publications & Presentations

PubMed

12 citations
Blood-based tests for multicancer early detection (PATHFINDER): a prospective cohort study.
Deb Schrag, Tomasz M Beer, Charles H McDonnell 3rd, Lincoln Nadauld, Christina A Dilaveri, Robert Reid, Catherine R Marinac, Karen C Chung, Margarita Lopatin, Eric T F...> ;Lancet. 2023 Oct 7
4 citations
The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer.
Arian Lundberg, Meng Zhang, Rahul Aggarwal, Haolong Li, Li Zhang, Adam Foye, Martin Sjöström, Jonathan Chou, Kevin Chang, Thaidy Moreno-Rodriguez, Raunak Shrestha, Avi...> ;Cancer Research. 2023 Aug 15
1 citations
Dying To Find Out: The Cost of Time at the Dawn of the Multicancer Early Detection Era.
Eric A Klein, Sarina Madhavan, Tomasz M Beer, Chetan Bettegowda, Minetta C Liu, Anne-Renee Hartman, Allan Hackshaw> ;Cancer Epidemiology, Biomarkers & Prevention. 2023 Aug 1
Dying to Find Out: The Cost of Time at the Dawn of the Multicancer Early Detection Era.
Eric A Klein, Sarina Madhavan, Tomasz M Beer, Chetan Bettegowda, Minetta C Liu, Anne-Renee Hartman, Allan Hackshaw> ;Cancer Epidemiology, Biomarkers & Prevention. 2023 May 15
24 citations
Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conferenc...
Sharifi, N., Silke Gillessen, Alberto Bossi, Ian D Davis, Johann de Bono, Karim Fizazi, Nicholas D James, Nicolas Mottet, Neal Shore, Eric Small, Matthew Smith, Christ...> ;European Journal of Cancer. 2023 May 1
5 citations
The Promise of Multicancer Early Detection.
Eric A Klein, Tomasz M Beer, Michael Seiden> ;The American Journal of Medicine. 2023 Mar 1
33 citations
Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal T...
Silke Gillessen, Alberto Bossi, Ian D Davis, Johann de Bono, Karim Fizazi, Nicholas D James, Nicolas Mottet, Neal Shore, Eric Small, Mathew Smith, Christopher Sweeney,...> ;European Urology. 2023 Mar 1
2 citations
Phase II Randomized Study of Salvage Radiation Therapy Plus Enzalutamide or Placebo for High-Risk Prostate-Specific Antigen Recurrent Prostate Cancer After Radical Pro...
Phuoc T Tran, Kathryn Lowe, Hua-Ling Tsai, Daniel Y Song, Arthur Y Hung, Jason W D Hearn, Steven Miller, James A Proudfoot, Matthew P Deek, Ryan Phillips, Tamara Lotan...> ;Journal of Clinical Oncology. 2023 Feb 20
Functional impact of androgen-targeted therapy on patients with castration-resistant prostate cancer.
Tomasz M Beer, Neal Shore, Alicia Morgans, Kerri Winters-Stone, Jeffrey S Wefel, Daniel J George> ;BJUI Compass. 2022 Nov 1
13 citations
The 5-Hydroxymethylcytosine Landscape of Prostate Cancer.
Martin Sjöström, Shuang G Zhao, Samuel Levy, Meng Zhang, Yuhong Ning, Raunak Shrestha, Arian Lundberg, Cameron Herberts, Adam Foye, Rahul Aggarwal, Junjie T Hua, Haolo...> ;Cancer Research. 2022 Nov 2
10 citations
Transcriptional profiling of matched patient biopsies clarifies molecular determinants of enzalutamide-induced lineage plasticity.
Thomas C Westbrook, Xiangnan Guan, Eva Rodansky, Diana Flores, Chia Jen Liu, Aaron M Udager, Radhika A Patel, Michael C Haffner, Ya-Mei Hu, Duanchen Sun, Tomasz M Beer...> ;Nature Communications. 2022 Sep 15
55 citations
Management of Patients with Advanced Prostate Cancer: Report from the Advanced Prostate Cancer Consensus Conference 2021.
Silke Gillessen, Andrew Armstrong, Gert Attard, Tomasz M Beer, Himisha Beltran, Anders Bjartell, Alberto Bossi, Alberto Briganti, Robert G Bristow, Muhammad Bulbul, Or...> ;European Urology. 2022 Jul 1
4 citations
What Experts Think About Prostate Cancer Management During the COVID-19 Pandemic: Report from the Advanced Prostate Cancer Consensus Conference 2021.
Fabio Turco, Andrew Armstrong, Gerhardt Attard, Tomasz M Beer, Himisha Beltran, Anders Bjartell, Alberto Bossi, Alberto Briganti, Rob G Bristow, Muhammad Bulbul, Orazi...> ;European Urology. 2022 Jul 1
Corrigendum to "What Experts Think About Prostate Cancer Management During the COVID-19 Pandemic: Report from the Advanced Prostate Cancer Consensus Conference 2021" [...
Fabio Turco, Andrew Armstrong, Gerhardt Attard, Tomasz M Beer, Himisha Beltran, Anders Bjartell, Alberto Bossi, Alberto Briganti, Rob G Bristow, Muhammad Bulbul, Orazi...> ;European Urology. 2022 Jul 1
11 citations
Statin and metformin use and outcomes in patients with castration-resistant prostate cancer treated with enzalutamide: A meta-analysis of AFFIRM, PREVAIL and PROSPER.
Anthony M Joshua, Andrew Armstrong, Megan Crumbaker, Howard I Scher, Johann de Bono, Bertrand Tombal, Maha Hussain, Cora N Sternberg, Silke Gillessen, Joan Carles, Kar...> ;European Journal of Cancer. 2022 Jul 1
5 citations
The Promise of Multicancer Early Detection. Comment on Pons-Belda et al. Can Circulating Tumor DNA Support a Successful Screening Test for Early Cancer Detection? The ...
Eric A Klein, Tomasz M Beer, Michael Seiden> ;Diagnostics. 2022 May 17
1 citations
A Phase II, Single-arm Trial of Sunitinib and Erlotinib in Advanced Renal Cell Carcinoma.
Zizhen Feng, Brendan D Curti, David I Quinn, John M Strother, Zunqiu Chen, Rebecca Agnor, Tomasz M Beer, Christopher W Ryan> ;Clinical Genitourinary Cancer. 2022 Oct 1
2 citations
Short-term ADT and Dose-escalated IMRT in Patients With Intermediate-risk Prostate Cancer: Benefit or Caution?
Carl M Post, Jenna M Kahn, Tomasz M Beer, Arthur Y Hung, Turina, C.> ;American Journal of Clinical Oncology. 2022 May 1
Multicancer early detection.
Eric A Klein, Tomasz M Beer, Michael Seiden> ;Clinical Chemistry and Laboratory Medicine. 2022 Apr 26
4 citations
Quality of Life of Prostate Cancer Survivors Participating in a Remotely Delivered Web-Based Behavioral Intervention Pilot Randomized Trial.
Crystal S Langlais, Yea-Hung Chen, Erin L Van Blarigan, Stacey A Kenfield, Elizabeth R Kessler, Kimi Daniel, Justin W Ramsdill, Tomasz M Beer, Rebecca E Graff, Kellie ...> ;Integrative Cancer Therapies. 2022 Apr 7
28 citations
Efficacy and Safety of Autologous Dendritic Cell-Based Immunotherapy, Docetaxel, and Prednisone vs Placebo in Patients With Metastatic Castration-Resistant Prostate Ca...
Nicholas J Vogelzang, Tomasz M Beer, Winald Gerritsen, Stéphane Oudard, Pawel Wiechno, Bozena Kukielka-Budny, Vladimir Samal, Jaroslav Hajek, Susan Feyerabend, Vincent...> ;JAMA Oncology. 2022 Apr 1
2 citations
A pilot feasibility study of Exercising Together© during radiation therapy for prostate cancer: a dyadic approach for patients and spouses.
Kerri M Winters-Stone, Karen S Lyons, Tomasz M Beer, Meghan B Skiba, Arthur Hung> ;Pilot and Feasibility Studies. 2021 Dec 8
3 citations
Randomized Phase 2 Trial of Abiraterone Acetate Plus Prednisone, Degarelix, or the Combination in Men with Biochemically Recurrent Prostate Cancer After Radical Prosta...
Karen A. Autio, Emmanuel S. Antonarakis, Tina M. Mayer, Daniel H. Shevrin, Mark N. Stein, Ulka N. Vaishampayan, Michael J. Morris, Susan F. Slovin, Elisabeth I. Heath,...> ;European Urology Open Science. 2021 Dec 1
2 citations
Examining developments in multicancer early detection: highlights of new clinical data from recent conferences.
Tomasz M Beer> ;The American Journal of Managed Care. 2021 Dec 1
11 citations
Lack of consensus identifies important areas for future clinical research: Advanced Prostate Cancer Consensus Conference (APCCC) 2019 findings.
Ursula M Vogl, Tomasz M. Beer, Ian D. Davis, Neal D. Shore, Christopher Sweeney, Piet Ost, Gerhardt Attard, Alberto Bossi, Johann S. de Bono, Charles G. Drake, Eleni E...> ;European Journal of Cancer. 2021 Nov 26
Join now to see all

Journal Articles

Activity of Platinum-Based Chemotherapy in Patients with Advanced Prostate Cancer with and Without DNA Repair Gene Aberrations
Himisha Beltran, Che-Kai Tsao, Tomasz M Beer, JAMA Network Open
Development and Validation of a Prognostic Model for Overall Survival in Chemotherapy-Naïve Men with Metastatic Castration-Resistant Prostate Cancer
G Sonpavde, C S Higano, T M Beer, Annals of Oncology

Press Mentions

Blood Tests That Detect Cancers Create Risks for Those Who Use ThemJune 10th, 2022
New Blood Test from Biotech Firm Planning to Hire 400 in RTP Can Detect 50+ Types of CancerJune 8th, 2021
Grail Launches Its 50-Cancer Galleri Blood Screening TestJune 7th, 2021
Join now to see all

Grant Support

Resistance And Response Mechanisms To Prostate Cancer TherapyNational Cancer Institute2006–2009
Solid TumorsNational Cancer Institute2005–2009
A Novel Vitamin D Target In Human Prostate CancerNational Cancer Institute2006–2007
Acupuncture For HOT Flashes In Prostate Cancer PatientsNational Center For Research Resources2005
Transdermal Estrogen In Androgen-Independent Prostate CancerNational Center For Research Resources2004–2005
Acupuncture For HOT Flashes In Prostate Cancer PatientsNational Cancer Institute2003–2004
Oregon Prostate Cancer Conference 2001National Cancer Institute2001–2003
Pulse Calcitriol For Prostate Cancer PreventionNational Cancer Institute2000
Calcitriol In Recurrent Prostate CancerNational Cancer Institute2000